GIANT BIOGENE HOLDING CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50 HKD | -2.25% |
|
+0.30% | +40.45% |
| Apr. 30 | Giant Biogene’s Profit Up 47% in 2023 | MT |
| Mar. 25 | Giant Biogene Holding Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Giant Biogene Holding Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
7f.4cOeCwJ7UWDD0URhT2ECivocb8sUNJMS6hYfLRenDgo.i7nkaG4DPQahpwEKLAxnuph4I6EgY6VApnRqaF3Rb2uqj_ZmOg82MJWTDQ~61252d12ba19126b4fa8a800edd5cd9e
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
50
HKD
Average target price
55.37
HKD
Spread / Average Target
+10.74%
High Price Target
59.1
HKD
Spread / Highest target
+18.20%
Low Price Target
52
HKD
Spread / Lowest Target
+4.00%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 2367 Stock
- Consensus Giant Biogene Holding Co., Ltd.
